Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
Sophie C. Cazanave, Alexei A. Podtelezhnikov, Kristian Jensen, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 59

Showing 26-50 of 59 citing articles:

A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis
Matthew C. Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo‐Villarin, et al.
iScience (2020) Vol. 24, Iss. 1, pp. 101931-101931
Open Access | Times Cited: 27
Influence of total polar compounds on lipid metabolism, oxidative stress and cytotoxicity in HepG2 cells
Jingjie Ju, Zhaojun Zheng, Yong‐Jiang Xu, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH
Mei‐Ju Hsu, Isabel Karkossa, I. Schäfer, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 350-350
Open Access | Times Cited: 25
Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring
Thomas W. Jackson, Garret L. Ryherd, Chris M. Scheibly, et al.
Toxicological Sciences (2020) Vol. 178, Iss. 2, pp. 264-280
Open Access | Times Cited: 23
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
Fatima Jamshed, Farzaneh Dashti, Xinshou Ouyang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 12, pp. 1824-1837
Open Access | Times Cited: 7
Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
Weiwei He, Yinxiang Huang, Xiulin Shi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression
Ravi Sonkar, Hong Ma, David J. Waxman
Toxicological Sciences (2024) Vol. 200, Iss. 2, pp. 324-345
Open Access | Times Cited: 2
A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?
Herbert Tilg, Maria Effenberger, Timon E. Adolph
Expert Opinion on Investigational Drugs (2019) Vol. 29, Iss. 2, pp. 103-106
Open Access | Times Cited: 20
Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology
Sarah Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 21, pp. 2850-2870
Open Access | Times Cited: 17
Coffee modulates insulin-hepatocyte nuclear factor-4α-Cyp7b1 pathway and reduces oxysterol-driven liver toxicity in a nonalcoholic fatty liver disease mouse model
Genta Kakiyama, Kei Minowa, Daniel Rodríguez‐Agudo, et al.
AJP Gastrointestinal and Liver Physiology (2022) Vol. 323, Iss. 5, pp. G488-G500
Open Access | Times Cited: 11
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
Ilaria Milani, Michela Codini, Gloria Guarisco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10795-10795
Open Access | Times Cited: 2
NAFLD-related HCC
Bubu A. Banini, Arun J. Sanyal
Advances in cancer research (2021), pp. 143-169
Closed Access | Times Cited: 15
Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet
Volodymyr Tryndyak, Rose Willett, Mark Avigan, et al.
Epigenetics (2022) Vol. 17, Iss. 11, pp. 1462-1476
Open Access | Times Cited: 9
Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model
Valeria Iannone, Ambrin Farizah Babu, Johnson Lok, et al.
Molecular Metabolism (2023) Vol. 78, pp. 101823-101823
Open Access | Times Cited: 5
Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: Primary and secondary gene responses with links to disease progression
Ravi Sonkar, Hong Ma, David J. Waxman
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Honey vesicle-like nanoparticles protect aged liver from non-alcoholic steatohepatitis
Baolong Liu, Phuong Linh Nguyen, Yu Han, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3661-3679
Open Access | Times Cited: 1
Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR‐based whole‐genome screening
Zhongzhou Si, Xinjie Guan, Xiangyun Teng, et al.
The FASEB Journal (2020) Vol. 34, Iss. 10, pp. 13776-13791
Open Access | Times Cited: 10
Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Devarapalli Ranjani Durga, Nadella Mounika, Pravallika Mudimala, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 12, pp. 1049-1064
Closed Access | Times Cited: 6
Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice
Volodymyr Tryndyak, Rose Willett, Suresh K. Nagumalli, et al.
AJP Gastrointestinal and Liver Physiology (2023) Vol. 324, Iss. 3, pp. G232-G243
Open Access | Times Cited: 3
Characterization of regulatory transcriptional mechanisms in hepatocyte lipotoxicity
Joaquín Pérez‐Schindler, Elyzabeth Vargas‐Fernández, Bettina Karrer‐Cardel, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Dysregulation of Bile Acids in Patients with NAFLD
Xinmu Zhang, Ruitang Deng
IntechOpen eBooks (2019)
Open Access | Times Cited: 6
Effects of Siberian fir terpenes extract Abisil on antioxidant activity, autophagy, transcriptome and proteome of human fibroblasts
Anastasiya V. Lipatova, George S. Krasnov, Pavel Vorobyov, et al.
Aging (2021) Vol. 13, Iss. 16, pp. 20050-20080
Open Access | Times Cited: 5
Hepatic transcriptional profile reveals the role of diet and genetic backgrounds on metabolic traits in female progenitor strains of the Collaborative Cross
Myungsuk Kim, M. Nazmul Huda, Annalouise O’Connor, et al.
Physiological Genomics (2021) Vol. 53, Iss. 5, pp. 173-192
Open Access | Times Cited: 4
Integrated transcriptomic landscape of the effect of anti‐steatotic treatments in high‐fat diet mouse models of non‐alcoholic fatty liver disease
Isabel Fuster‐Martínez, José F. Català-Senent, Marta R. Hidalgo, et al.
The Journal of Pathology (2024)
Open Access
Understanding Cardiometabolic Diseases Through Transcriptomic Approach
Kashish Gupta, Apurvasinh Puvar, Madhvi Joshi, et al.
Advances in biochemistry in health and disease (2024), pp. 333-363
Closed Access

Scroll to top